Navigation Links
New therapeutic target identified for rheumatoid arthritis
Date:11/5/2008

Researchers at Hospital for Special Surgery have identified a potential new therapeutic target that could be used to treat inflammatory disorders, such as rheumatoid arthritis.

The study, published online ahead of print, will appear Nov. 15 in the journal Immunity. Specifically, the study reveals that two molecular pathways, the Notch and Toll-like receptor pathways, are linked and that manipulating a protein called RBP-J involved in both pathways, could serve as a treatment for rheumatoid arthritis.

"This is a basic science papers with translational and clinical implications, as it identifies a potential new therapeutic target in the treatment of inflammatory disorders," said Lionel Ivashkiv, M.D., director of Basic Research at Hospital for Special Surgery in New York City. He said that drugs, so-called gamma secretase inhibitors that hit this new target, are actually in trials for the treatment of another disease, leukemia.

Previous research has shown that activation of certain cell surface receptors called Toll-like receptors leads to the production of inflammatory proteins or cytokines. Researchers have also known that a protein called interferon gamma can increase inflammatory response, but they didn't know the exact mechanism.

To find out, they turned to microarray analysis, a method of surveying an entire genome to determine which genes are being expressed or which are responsible for a certain condition. Using this technology with human macrophages, white blood cells that are vital to the development of inflammatory response, they identified a subset of genes that were turned on by the activation of Toll-like receptors and inhibited by interferon gamma. This subset of genes included genes that are involved in the Notch signaling pathway. For some time, scientists have known that the Notch signaling pathway regulates cell differentiation, proliferation, survival and development.

"Before this study,
'/>"/>

Contact: Phyllis Fisher
fisherp@hss.edu
212-606-1197
Hospital for Special Surgery
Source:Eurekalert

Page: 1 2

Related biology news :

1. Using evolution, UW team creates a template for many new therapeutic agents
2. The endocannabinoids: Functional roles and therapeutic opportunities
3. Potential new therapeutic molecular target to fight cancer
4. Galapagos and Cystic Fibrosis Foundation Therapeutics announce drug discovery collaboration
5. Methadone even at therapeutic levels can kill
6. Nucleonics initiates hepatitis B clinical trial with expressed interfering RNA therapeutic
7. Synthetic molecules may be less expensive alternative to therapeutic antibodies, researchers find
8. New technology enhances therapeutic potential of cord blood stem cells
9. Novel therapeutic strategy for colon cancer treatment
10. TG2 identified as potential therapeutic target in chemo-resistant ovarian cancer
11. Michael J. Fox Foundation awards $2.4M for validation of therapeutic targets for Parkinsons
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... -- Plants have a symbiotic relationship with certain ... nutrients and defend against invaders an important ... vegetables. Now, scientist have discovered that plants may ... ensuring that sprouting plants are colonized from the ... Dame, presented their findings today at the 5th ...
(Date:9/29/2014)... Food and Brand Lab pilot study, published in ... National School Lunch Program (NSLP) by 9% and overall ... Move to Schools (CMTS), an initiative of Michelle Obama,s ... to provide nutrition instruction to students and culinary advice ... event was held in an Upstate New York high ...
(Date:9/29/2014)... the world,s needs to make cheaper and more ... more efficient catalytic materials and processes must be ... Wayne State University, is tackling this problem with ... National Science Foundation. , The nearly $1.5 million ... Electrocatalytic Cascade Reactions," was to Eranda Nikolla, Ph.D., ...
Breaking Biology News(10 mins):Plants prepackage beneficial microbes in their seeds 2Chefs move to schools can increase school meal participation and vegetable intake among students 2Wayne State research aims to develop new, more efficient catalytic materials 2
... Biochemistry and Molecular Biology (ASBMB) has announced that ... the Cleveland Clinic,s Lerner Research Institute and emeritus ... is the recipient of the society,s 2011 Herbert ... The lectureship recognizes outstanding lifetime scientific ...
... Researchers at the University of Oklahoma ... new type of gene therapy to prevent blindness caused by retinitis ... this debilitating disease. ... Federation of American Societies for Experimental Biology (FASEB). The research, ...
... This release is available in German . ... researchers in Germany, the Deutsche Forschungsgemeinschaft (DFG, German Research ... decision was made by the DFG,s relevant Grants Committee ... doctoral researchers to complete their training at a highly ...
Cached Biology News:Dr. George Stark receives 2011 Herbert Tabor/Journal of Biological Chemistry Lectureship from ASBMB 2OU researchers find way to prevent blindness in research model for retinitis pigmentosa 2DFG establishes 12 new research training groups 2DFG establishes 12 new research training groups 3DFG establishes 12 new research training groups 4DFG establishes 12 new research training groups 5DFG establishes 12 new research training groups 6
(Date:9/29/2014)... -- The 12th Cold Chain GDP & Temperature Management ... at the John B. Hynes Convention Center. The remarkable ... for a weeklong conference attracting industry executives from around ... to cover the industry,s most pressing topics, with an ... range products, GDP compliance requirements and supply chain integrity. ...
(Date:9/29/2014)...  Perrigo Company plc (NYSE: PRGO ... a portfolio of preclinical research assets, which it ... Corporation plc, to drug discovery and development company, ... will receive an upfront payment in addition to ... future sales derived from the portfolio. ...
(Date:9/29/2014)... Sept. 29, 2014  Xcenda, the strategic consulting ... pharmaceutical sourcing and distribution service companies, recently conducted ... This research was analyzed in an economic model ... with an increase in life years and a ... population-level coffee consumption across the United ...
(Date:9/29/2014)... Westbridge Agricultural Products announced today ... highly effective new tool for organic growers. SUPPRESS™ ... contact herbicide for post-emergent, non-selective weed control for ... The formulation is an emulsifiable concentrate that has ... (OMRI) for use in organic food production. , ...
Breaking Biology Technology:12th Cold Chain GDP & Temperature Management Logistics Global Forum Officially Kicks Off in Boston 2Perrigo Announces the Out-Licensing of Preclinical Assets to Imago Pharmaceuticals 2Perrigo Announces the Out-Licensing of Preclinical Assets to Imago Pharmaceuticals 3Perrigo Announces the Out-Licensing of Preclinical Assets to Imago Pharmaceuticals 4Coffee Consumption May Increase Survival and Reduce Healthcare Costs 2Coffee Consumption May Increase Survival and Reduce Healthcare Costs 3Westbridge Receives EPA Approval for Its New SUPPRESS™ Herbicide EC 2
... Oct. 1 Halozyme Therapeutics, Inc.,(Nasdaq: HALO ... the extracellular matrix, today announced that it will,host ... at 12:15 p.m. EDT. A,webcast of the presentations ... PRESENTATIONS, -- Strategic Company Overview, Jonathan ...
... 1 Celsis Rapid Detection, a division of,Celsis ... Frost & Sullivan,2008 North American Growth Strategy Leadership ... the Manufacture and Release of,Pharmaceuticals., "The Celsis ... that enables pharmaceutical companies to significantly reduce,production cycle ...
... and VANCOUVER, Oct. 1 /PRNewswire-FirstCall/ - OncoGenex,Pharmaceuticals, Inc ... BioContact Quebec,2008 annual partnering symposium on October 2 ... the Chateau Frontenac in Quebec City. OncoGenex, President ... corporate overview,at the conference, including a discussion of ...
Cached Biology Technology:Halozyme Therapeutics to Host Research Day for Investors and Analysts 2Celsis Receives Frost & Sullivan 2008 Best Practices Award 2Celsis Receives Frost & Sullivan 2008 Best Practices Award 3
...
Anti-Tissue Trans-glutaminase (IgA) EIA Sample Size: 10 l...
... Methylation-specific PCR (MSP) is a ... abnormal gene methylation utilizing small amounts ... an initial bisulfite reaction to modify ... with specific primers designed to distinguish ...
... The iEMS Incubator/Shaker HT ... Thus, the iEMS Incubator/Shaker HT ... as DNA hybridization and primer ... is available as a one-cabinet ...
Biology Products: